TITLE

Drug approval system questioned in US and Canada

AUTHOR(S)
Egertson, Laura
PUB. DATE
February 2005
SOURCE
CMAJ: Canadian Medical Association Journal;2/1/2005, Vol. 172 Issue 3, p317
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the plans of Health Canada to consider implementing pilot activities that would allow for concurrent reviews of drugs in Canada and the U.S. in 2005. Objectives of a memorandum of understanding between the U.S. and Canada in which the joint reviews would take place; Criticism of the quality of drug approvals and postmarking system of the U.S. Food and Drug Administration (FDA); Concerns of the organization Public Citizen about the drug approval process of the FDA; Problems in the review function.
ACCESSION #
15783961

 

Related Articles

  • Pipeline preview.  // Formulary;May2005, Vol. 40 Issue 5, p144 

    Presents actions taken by the U.S. Food and Drug Administration concerning certain drugs. Approvable designations; Recommendations for approval; Priority review; Fast-track designations.

  • FOREWORD. Esherick, Donald // Drug Therapy & Childhood Adolescent Disorders;2003, p9 

    When a new drug is developed, a pharmaceutical company usually intends that drug to treat a single disease or family of diseases. The U.S. Food and Drug Administration (FDA) reviews the company's research to determine if the drug is safe for use in the population at large and if it effectively...

  • Tysabri: no longer out of TOUCH in the US.  // Reactions Weekly;6/17/2006, Issue 1106, p3 

    Reports on the U.S. Food and Drug Administration approval of an application for the reintroduction of the drug Tysabri in the U.S. Bases of the reintroduction; Reason for the drug's suspension; Elements of the TOUCH program developed by the Administration's Peripheral and Central Nervous...

  • FDA Drug Approval to Change its Ways? Elliott, William T. // Infectious Disease Alert;May2008, Vol. 27 Issue 8, p1 

    The article reports on the issue regarding the need to change the drug approval process of the U.S. Food and Drug Administration (FDA). It states that such process is being scrutinized that mainly focused on the Prescription Drug User Fee Act (PDUFA), which requires deadlines for approval of the...

  • FDA actions in brief.  // Formulary;May2007, Vol. 42 Issue 5, p284 

    The article presents several drugs approved by the U.S. Food and Drug Administration. The protein C concentrate Ceprotin was approved as an alternative to a therapy in patients with blood-clotting complications associated with severe congenital Protein C deficiency. The H5N1 vaccine has been...

  • Drug name confusion may cause medication errors.  // Hem/Onc Today;6/10/2013, Vol. 14 Issue 11, p46 

    The article explores the warning issued by the U.S. Food and Drug Administration (FDA) on the incorrect use of non-proprietary name for ado-trastuzumab emtansine, which is nonproprietary name approved by the FDA for Kadcyla (Genentech).

  • accelerated approval:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p3 

    A definition of the term "accelerated approval" is presented. It refers to a regulatory mechanism established by the U.S. Food and Drug Administration in an effort to speed products for deadly diseases, such as AIDS and some cancers, to market. Early approval is based on laboratory markers...

  • drug approval:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p78 

    A definition of the term "drug approval" is presented. It refers to the complex process by which therapeutic agents are certified safe and effective for human use if prescribed and taken according to directions. The Food and Drug Administration is responsible for approving all such substances in...

  • Study: No link between drug approval speed and safety.  // Pharmaceutical Representative;Dec2005, Vol. 35 Issue 12, p12 

    The article discusses a research conducted by the Tufts Center for the Study of Drug Development which indicates that faster approval of new drugs by the U.S. Food and Drug Administration (FDA) has not increased the number of prescription drugs withdrawn for safety reasons in the U.S. There was...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics